| PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia F McClanahan, B Hanna, S Miller, AJ Clear, P Lichter, JG Gribben, ... Blood, The Journal of the American Society of Hematology 126 (2), 203-211, 2015 | 210 | 2015 |
| Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo BS Hanna, F McClanahan, H Yazdanparast, N Zaborsky, V Kalter, ... Leukemia 30 (3), 570-579, 2016 | 137 | 2016 |
| Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme W Feng, D Kawauchi, H Körkel-Qu, H Deng, E Serger, L Sieber, ... Nature communications 8 (1), 14758, 2017 | 114 | 2017 |
| Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues BS Hanna, PM Roessner, H Yazdanparast, D Colomer, E Campo, ... Leukemia 33 (3), 625-637, 2019 | 70 | 2019 |
| PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia BS Hanna, PM Roessner, A Scheffold, BMC Jebaraj, Y Demerdash, ... Leukemia 33 (6), 1427-1438, 2019 | 67 | 2019 |
| Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton PB Knudsen, B Hanna, S Ohl, L Sellner, T Zenz, H Döhner, ... Leukemia 28 (6), 1289-1298, 2014 | 61 | 2014 |
| Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity BS Hanna, L Llao-Cid, M Iskar, PM Roessner, LC Klett, JKL Wong, Y Paul, ... Immunity 54 (12), 2825-2841. e10, 2021 | 58 | 2021 |
| Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in E-TCL1 mice BS Hanna, H Yazdanparast, Y Demerdash, PM Roessner, R Schulz, ... Haematologica 106 (4), 968, 2021 | 38 | 2021 |
| EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia L Llaó-Cid, PM Roessner, V Chapaprieta, S Öztürk, T Roider, M Bordas, ... Leukemia 35 (11), 3152-3162, 2021 | 37 | 2021 |
| Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia BS Hanna, S Öztürk, M Seiffert Molecular Immunology 110, 77-87, 2019 | 37 | 2019 |
| Interferon-α2b treatment for COVID-19 is associated with improvements in lung abnormalities Q Zhou, MR MacArthur, X He, X Wei, P Zarin, BS Hanna, ZH Wang, ... Viruses 13 (1), 44, 2020 | 34 | 2020 |
| Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin C Dürr, BS Hanna, A Schulz, F Lucas, M Zucknick, A Benner, A Clear, ... haematologica 103 (4), 688, 2018 | 33 | 2018 |
| The gut microbiota promotes distal tissue regeneration via RORγ+ regulatory T cell emissaries BS Hanna, G Wang, S Galván-Peña, AO Mann, RN Ramirez, ... Immunity 56 (4), 829-846. e8, 2023 | 32 | 2023 |
| IL-17A–producing γδT cells promote muscle regeneration in a microbiota-dependent manner AO Mann, BS Hanna, AR Muñoz-Rojas, I Sandrock, I Prinz, C Benoist, ... Journal of Experimental Medicine 219 (5), e20211504, 2022 | 23 | 2022 |
| CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion L Llaó Cid, BS Hanna, M Iskar, PM Roessner, S Öztürk, P Lichter, ... Leukemia & Lymphoma 61 (2), 351-356, 2020 | 18 | 2020 |
| Extracellular vesicles in chronic lymphocytic leukemia F Haderk, B Hanna, K Richter, M Schnölzer, T Zenz, S Stilgenbauer, ... Leukemia & lymphoma 54 (8), 1826-1830, 2013 | 18 | 2013 |
| Rejection of adoptively transferred E [micro]-TCL1 chronic lymphocytic leukemia cells in C57BL/6 substrains or knockout mouse lines S Ozturk, PM Roessner, L Schulze-Edinghausen, H Yazdanparast, ... Leukemia 33 (6), 1514-1520, 2019 | 16 | 2019 |
| TBET‐expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice PM Roessner, BS Hanna, S Öztürk, R Schulz, L Llaó Cid, H Yazdanparast, ... British journal of haematology 189 (1), 133-145, 2020 | 15 | 2020 |
| Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia E Lee‐Vergés, BS Hanna, H Yazdanparast, V Rodríguez, ML Rodríguez, ... International journal of cancer 144 (11), 2762-2773, 2019 | 15 | 2019 |
| Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients S Öztürk, Y Paul, S Afzal, I Gil-Farina, A Jauch, PM Bruch, V Kalter, ... Leukemia 36 (2), 464-475, 2022 | 5 | 2022 |
